Advertisement
Screener

Acorda Therapeutics, Inc. Patents: Active

Acorda Therapeutics, Inc. Active Patents

7 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-07-13: Application 17374285; Invention SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE; Applicant Acorda Therapeutics, Inc.; Status Patented Case.
  • 2017-08-10: Application 15674053; Invention METHODS FOR DETECTING CARDIAC DAMAGE; Applicant Acorda Therapeutics, Inc.; Status Patented Case.
  • 2017-07-25: Application 15658967; Invention METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS; Applicant Acorda Therapeutics, Inc.; Status Patented Case.
  • 2016-11-21: Application 15357586; Invention COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING CNS NEUROLOGICAL INJURY; Applicant Acorda Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2021-07-1317374285SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINEAcorda Therapeutics, Inc.Patented Case2024-07-0912029820US20210338590A1
Joseph E. Cobb JR.
Thomas B. Gold
Rohini D'Souza
Susan L. Way
United States
United States
United States
United States
GEMBEH, SHIRLEY V
2017-08-1015674053METHODS FOR DETECTING CARDIAC DAMAGEAcorda Therapeutics, Inc.Patented Case2019-04-1610258667US20180028610A1
Xinhua Yan
Anthony O. Caggiano
United States
United States
CHEU, CHANGHWA J
2017-07-2515658967METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELSAcorda Therapeutics, Inc.Patented Case2020-06-0910675331US20180055909A1
Haesun Kim
Anthony O. Caggiano
United States
United States
EMCH, GREGORY S
2016-11-2115357586COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING CNS NEUROLOGICAL INJURYAcorda Therapeutics, Inc.Patented Case2020-06-0210668131US20170252406A1
Anthony Caggiano
Jennifer Iaci
United States
United States
CHERNYSHEV, OLGA N
2014-01-1314153695Methods for Detecting Cardiac DamageACORDA THERAPEUTICS, INC.Patented Case2016-05-039329171US20140378377A1
Xinhua Yan
Anthony O. Caggiano
United States
United States
CHEU, CHANGHWA J
2013-05-2913904654Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart FailureAcorda Therapeutics, Inc.Patented Case2015-12-019198951US20130324466A1
Anthony O. Caggiano
Anindita Ganguly
Jennifer Iaci
Thomas Parry
United States
United States
United States
United States
LOCKARD, JON MCCLELLAND
2013-03-2913853386Method for Achieving Desired Glial Growth Factor 2 Plasma LevelsACORDA THERAPEUTICS, INC.Patented Case2016-03-019272015US20130345131A1
Haesun Kim
Anthony O. Caggiano
United States
United States
EMCH, GREGORY S